The Global Fund allocates US$349,779,344 for 2024-2026

Zambia has been allocated US$349,779,344 to support the national response to HIV, tuberculosis (TB), and malaria as well as to build resilient and sustainable systems for health (RSSH). This amount constitutes an increase of almost 11% compared to the 2021-2023 allocation.

The proposed budgets per disease component may be reviewed and revised by the CCM Zambia based on available evidence. The Zambia applications will have to indicate the intended investment amount for RSSH for each disease component. Due to high co-infection of TB and HIV, Zambia is required to submit TB/HIV as a joint funding request.

Additionally, Zambia is eligible for the following catalytic Matching Funds:

• US$3,000,000 for HIV pre-exposure prophylaxis (PrEP);
• US$4,000,000 to find and successfully treat the missing people with drug-susceptible TB and drug-resistant TB; and
• US$5,400,000 for effective community systems and responses contributing to improved health outcomes and equitable access to integrated people-centered quality services.

Zambia is also eligible for the following catalytic Strategic Initiatives:

• integrated lab systems strengthening; and
• effective CS&R contributing to improved health outcomes and equitable access to integrated people-centered quality services

The funding requests need to be developed through inclusive and transparent country dialogues with a broad range of stakeholders, including key and vulnerable populations. Zambia is requested to adopt the “Full Review funding request”. Find the CCM Roadmap here.